Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 71.00
0.00 (0.00%)
Aug 28, 2026, 1:30 PM CST
Excelsior Medical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,336 | 2,847 | 4,189 | 2,615 | 2,507 | 3,072 |
Short-Term Investments | 1,193 | 687.35 | 858.82 | 791.28 | 721.62 | 699.4 |
Cash & Short-Term Investments | 4,528 | 3,534 | 5,048 | 3,406 | 3,229 | 3,772 |
Cash Growth | 58.15% | -29.98% | 48.21% | 5.50% | -14.40% | 6.11% |
Accounts Receivable | 2,397 | 2,171 | 2,183 | 2,279 | 2,031 | 1,908 |
Other Receivables | 3,026 | 3,037 | 3,424 | 3,536 | 2,998 | 2,567 |
Receivables | 5,424 | 5,208 | 5,607 | 5,815 | 5,029 | 4,475 |
Inventory | 1,429 | 1,392 | 1,393 | 1,247 | 1,161 | 910.24 |
Other Current Assets | 291.31 | 232.18 | 173.13 | 223.65 | 109.55 | 150.59 |
Total Current Assets | 11,672 | 10,366 | 12,221 | 10,692 | 9,528 | 9,308 |
Property, Plant & Equipment | 1,910 | 1,028 | 1,121 | 1,071 | 1,028 | 914.16 |
Long-Term Investments | 4,221 | 5,414 | 4,907 | 4,917 | 4,536 | 3,558 |
Goodwill | 198.71 | 29.39 | 28.95 | 28.25 | 27.76 | 27.39 |
Other Intangible Assets | 18.83 | 17.37 | 18.18 | 16.91 | 3.87 | 5.62 |
Long-Term Deferred Tax Assets | 110.8 | 115.36 | 108.56 | 137 | 158.75 | 202.41 |
Other Long-Term Assets | 1,797 | 1,673 | 1,679 | 1,159 | 1,168 | 1,072 |
Total Assets | 21,156 | 18,977 | 20,368 | 18,080 | 16,483 | 15,105 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,023 | 1,146 | 978.97 | 974.73 | 1,000 | 947.53 |
Accrued Expenses | 2,435 | 2,111 | 4,606 | 2,961 | 2,739 | 2,254 |
Short-Term Debt | 641.55 | 1,343 | 917.53 | 1,135 | 535.13 | 479.97 |
Current Portion of Leases | 241.58 | 140.41 | 128.34 | 69.97 | 90.86 | 72.24 |
Current Income Taxes Payable | 130.21 | 108.87 | 101.22 | 143.37 | 98.44 | 63.88 |
Current Unearned Revenue | 545.48 | 572.22 | 543.6 | 559.17 | 484.94 | 379.22 |
Other Current Liabilities | 973.48 | 770.39 | 1,013 | 835.21 | 803.35 | 758.56 |
Total Current Liabilities | 5,990 | 6,192 | 8,289 | 6,679 | 5,752 | 4,955 |
Long-Term Debt | 350 | 350 | 2.68 | 0.58 | 0.53 | - |
Long-Term Leases | 1,177 | 320.28 | 377.83 | 236.83 | 182.05 | 209.78 |
Pension & Post-Retirement Benefits | 5.62 | 5.02 | 4.37 | 8.88 | 9.38 | 12.47 |
Long-Term Deferred Tax Liabilities | 356.31 | 369.85 | 322.49 | 235.07 | 233.8 | 176.7 |
Other Long-Term Liabilities | 72.31 | 15.44 | 14.63 | 6.85 | 7.39 | 5.31 |
Total Liabilities | 7,952 | 7,253 | 9,011 | 7,167 | 6,185 | 5,359 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,884 | 1,716 | 1,634 | 1,556 | 1,482 | 1,411 |
Additional Paid-In Capital | 4,249 | 3,391 | 3,383 | 3,288 | 3,276 | 3,276 |
Retained Earnings | 3,464 | 3,741 | 3,620 | 3,503 | 3,344 | 3,193 |
Comprehensive Income & Other | 216.77 | 344.95 | 333.49 | 266.66 | 97.49 | -142.1 |
Total Common Equity | 9,813 | 9,192 | 8,970 | 8,613 | 8,200 | 7,738 |
Minority Interest | 3,391 | 2,532 | 2,387 | 2,300 | 2,097 | 2,007 |
Shareholders' Equity | 13,204 | 11,725 | 11,357 | 10,913 | 10,297 | 9,746 |
Total Liabilities & Equity | 21,156 | 18,977 | 20,368 | 18,080 | 16,483 | 15,105 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,410 | 2,154 | 1,426 | 1,442 | 808.58 | 761.99 |
Net Cash (Debt) | 2,118 | 1,381 | 3,622 | 1,964 | 2,420 | 3,010 |
Net Cash Growth | 73.22% | -61.88% | 84.42% | -18.85% | -19.59% | 5.90% |
Net Cash Per Share | 11.54 | 8.01 | 21.03 | 11.40 | 14.04 | 17.45 |
Filing Date Shares Outstanding | 188.37 | 171.57 | 171.57 | 171.57 | 171.57 | 171.57 |
Total Common Shares Outstanding | 188.37 | 171.57 | 171.57 | 171.57 | 171.57 | 171.57 |
Working Capital | 5,682 | 4,174 | 3,932 | 4,013 | 3,776 | 4,353 |
Book Value Per Share | 52.10 | 53.58 | 52.28 | 50.20 | 47.80 | 45.10 |
Tangible Book Value | 9,596 | 9,146 | 8,923 | 8,568 | 8,169 | 7,705 |
Tangible Book Value Per Share | 50.94 | 53.31 | 52.01 | 49.94 | 47.61 | 44.91 |
Land | 149.5 | 148.75 | 144.51 | 137.82 | 144.18 | 140.67 |
Buildings | 250.22 | 248.43 | 238.28 | 226.57 | 258.16 | 250.73 |
Machinery | 1,209 | 1,103 | 1,103 | 1,028 | 915.04 | 811.13 |
Construction In Progress | 45.53 | 45.61 | 39.02 | 24.55 | 31.58 | 5.05 |
Leasehold Improvements | 286.56 | 15.73 | 15.73 | 10.66 | 1.77 | - |